Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the relative bioavailability of ReFacto AF as
compared to ReFacto, when each is administered as 2-minute bolus infusions.